Kezdőlap › Prosztatarák › Pennsylvania › Philadelphia
Prosztatarák klinikai vizsgálatok: Philadelphia, PA
44 Prosztatarák vizsgálat keres résztvevőket Philadelphia és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Toborzás folyamatban1/2. fázis
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Toborzás folyamatban3. fázis
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mérföldre
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mérföldre
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Toborzás folyamatban1. fázis
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
DESTINY-PANTUMOUR04
Toborzás folyamatbanMegfigyeléses tanulmány
- Research Site, Philadelphia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Toborzás folyamatban3. fázis
- Fox Chase Cancer Center ( Site 0076), Philadelphia
- MidLantic urology ( Site 0022), Bala-Cynwyd · 5 mérföldre
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Toborzás folyamatban3. fázis
- MidLantic urology, Bala-Cynwyd · 5 mérföldre
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Toborzás folyamatban2/3. fázis
- Fox Chase Cancer Center, Philadelphia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Toborzás folyamatban2. fázis
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Toborzás folyamatban3. fázis
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Toborzás folyamatban1/2. fázis
- GSK Investigational Site, Philadelphia
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Toborzás folyamatban1. fázis
- Thomas Jefferson University, Philadelphia
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Toborzás folyamatban
- MidLantic Urology, Bala-Cynwyd · 5 mérföldre
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Toborzás folyamatban3. fázis
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mérföldre
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mérföldre
A Study of Tarlatamab for People With Prostate Cancer
Toborzás folyamatban2. fázis
- Thomas Jefferson University Hospital, Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Toborzás folyamatban1. fázis
- Thomas Jefferson University, Philadelphia
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Toborzás folyamatban2. fázis
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Toborzás folyamatban3. fázis
- Penn Presbyterian Medical Center, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Toborzás folyamatban1/2. fázis
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Toborzás folyamatban1. fázis
- Thomas Jefferson University Honickman Center, Philadelphia
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Toborzás folyamatban1. fázis
- Thomas Jefferson University, Philadelphia
PSMA PET Combined With MRI for the Detection of PCa
Toborzás folyamatban3. fázisEgészséges önkéntesek is jelentkezhetnek
- MidLantic Urology, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Toborzás folyamatban1. fázis
- Investigative Site #109, Philadelphia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Toborzás folyamatban3. fázis
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mérföldre
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mérföldre
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Toborzás folyamatban1. fázis
- MidLantic Urology, Bala-Cynwyd · 5 mérföldre
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Toborzás folyamatban1. fázis
- Thomas Jefferson University, Philadelphia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Toborzás folyamatban1/2. fázis
- Thomas Jefferson University Hospital, Philadelphia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Toborzás folyamatban2. fázis
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
TERPS Trial for de Novo Oligometastic Prostate Cancer
Toborzás folyamatban2. fázis
- Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Toborzás folyamatbanMegfigyeléses tanulmány
- Fox Chase Cancer Center - Temple Health, Philadelphia
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Toborzás folyamatban
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Toborzás folyamatban2/3. fázis
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Toborzás folyamatban1/2. fázis
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Toborzás folyamatban1/2. fázis
- Research Site, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Toborzás folyamatban1. fázis
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Hypofractionated WPPT With HDR Boost
Toborzás folyamatban2. fázis
- University of Pennsylvania, Philadelphia
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Toborzás folyamatban1. fázis
- MidLantic Urology, Bala-Cynwyd · 5 mérföldre
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Toborzás folyamatban4. fázis
- Albert Einstein Healthcare Network, Philadelphia
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Toborzás folyamatban3. fázis
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mérföldre
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mérföldre
Prostate Tissue BioBank
Toborzás folyamatbanMegfigyeléses tanulmány
- University of Pennsylvania, Philadelphia
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
Toborzás folyamatban
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Philadelphia
Prosztatarák vizsgálatok más városokban
- New York City, NY103 tanulmány
- Houston, TX76 tanulmány
- Los Angeles, CA61 tanulmány
- Boston, MA59 tanulmány
- St. Louis, MO46 tanulmány
- Chicago, IL45 tanulmány
- San Francisco, CA45 tanulmány
- Baltimore, MD43 tanulmány
- Nashville, TN43 tanulmány
- Seattle, WA42 tanulmány
- Washington, DC38 tanulmány
- Dallas, TX36 tanulmány
Egyéb vizsgálatok: Philadelphia
- Rák (minden típus)59 tanulmány
- Mellrák56 tanulmány
- Nem kis sejtes tüdőrák51 tanulmány
- Áttétes rák46 tanulmány
- Kolorektális rák44 tanulmány
- Petefészekrák44 tanulmány
- Tüdőrák36 tanulmány
- Akut mieloid leukémia34 tanulmány
- Szívelégtelenség31 tanulmány
- Endometriális rák28 tanulmány
- Depresszió26 tanulmány
- Hasnyálmirigyrák26 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.